Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06107452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability

Study acronym: PROPIU
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion date changed from estimate of May 2026 to Sep 12, 2025 · Enrollment target: estimated 110 to confirmed 102 · Study completion date changed from estimate of May 2026 to Oct 27, 2025 · 3 more Show 6 more changesShow less
    • Primary completion date changed from estimate of May 2026 to Sep 12, 2025
    • Enrollment target: estimated 110 to confirmed 102
    • Study completion date changed from estimate of May 2026 to Oct 27, 2025
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 5 of 10 entries
    • Site details revised
  2. Primary and study completion dates: Jun 2025 to May 2026v5
  3. Primary completion date: Dec 2024 to Jun 2025 Completion date: Feb 2025 to Jun 2025v4 Show 1 more changeShow less
    • Completion date: Feb 2025 to Jun 2025
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jan 2024 to Feb 5, 2024 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Jan 2024 to Feb 5, 2024
    • Site details revised
  5. Start date: Oct 31, 2023 to Jan 2024 Primary completion date: Dec 1, 2024 to Dec 2024 · Completion date: Feb 1, 2025 to Feb 2025v2 Show 2 more changesShow less
    • Primary completion date: Dec 1, 2024 to Dec 2024
    • Completion date: Feb 1, 2025 to Feb 2025
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Cardiac readaptation aims to mitigate cardiovascular risks and enhance the quality of life among coronary patients. Our research laboratory has an international expertise in training optimization in top-athletes and a previous study has demonstrated the efficacy of optimizing cardiac rehabilitation through the power-force-velocity profile (PFVP). The findings exhibited significant improvements in aerobic capacity, muscular strength, and cardiovascular parameters among patients who were trained based on their PFVP. Guided training utilizing heart rate variability (HRV) is also garnering increasing interest as a means to optimize training load and promote recovery
Trial Details
NCT Number NCT06107452
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Conditions Acute Coronary Syndrome
Enrollment 102 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov